EMEA recommends new warnings and contraindications for rosiglitazone

View source ↗

Summary

The European Medicines Agency recommends new warnings and contraindications for rosiglitazone to address cardiovascular and other risks.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Rosiglitazone (rosiglitazone)